{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:23Z","timestamp":1740144143090,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s40266-023-01062-0","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T20:31:26Z","timestamp":1693600286000},"page":"1009-1015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Methodological Considerations for Describing Medication Changes in Relation to Clinical Events and Death: An Applied Example in Patients with Type 2 Diabetes and Cancer"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-4555","authenticated-orcid":false,"given":"Karl Sebastian","family":"Johansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonny Studsgaard","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel Bring","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006740","volume":"5","author":"PD Baade","year":"2015","unstructured":"Baade PD, Youlden DR, Andersson TM-L, et al. Estimating the change in life expectancy after a diagnosis of cancer among the Australian population. BMJ Open. 2015;5: e006740.","journal-title":"BMJ Open"},{"issue":"61","key":"1062_CR2","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1111\/jgs.12514","volume":"2013","author":"American Geriatrics Society Expert Panel on the care of older adults with diabetes mellitus","year":"2013","unstructured":"American Geriatrics Society Expert Panel on the care of older adults with diabetes mellitus. Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update. J Am Geriatr Soc. 2013;2013(61):2020\u20136.","journal-title":"J Am Geriatr Soc"},{"key":"1062_CR3","unstructured":"IDF Managing Older People with Type 2 Diabetes\u2014Global guideline [Internet]. Brussels: International Diabetes Federation; 2017. https:\/\/idf.org\/e-library\/guidelines\/78-global-guideline-for-managing-older-people-with-type-2-diabetes.html."},{"key":"1062_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40266-020-00774-x","volume":"37","author":"A Burghle","year":"2020","unstructured":"Burghle A, Lundby C, Ryg J, et al. Attitudes towards deprescribing among older adults with limited life expectancy and their relatives: a systematic review. Drugs Aging. 2020;37:503\u201320.","journal-title":"Drugs Aging"},{"key":"1062_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/bcp.13861","volume":"85","author":"C Lundby","year":"2019","unstructured":"Lundby C, Graabaek T, Ryg J, et al. Health care professionals\u2019 attitudes towards deprescribing in older patients with limited life expectancy: a systematic review. Br J Clin Pharmacol. 2019;85:868\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"1062_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.12788\/j.suponc.0004","volume":"11","author":"M Krishnan","year":"2013","unstructured":"Krishnan M, Temel JS, Wright AA, et al. Predicting life expectancy in patients with advanced incurable cancer: a review. J Support Oncol. 2013;11:68\u201374.","journal-title":"J Support Oncol"},{"key":"1062_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0269216318801124","volume":"33","author":"K Paque","year":"2019","unstructured":"Paque K, Vander Stichele R, Elseviers M, et al. Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review. Palliat Med. 2019;33:37\u201348.","journal-title":"Palliat Med"},{"key":"1062_CR8","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/aogs.13413","volume":"97","author":"A Potteg\u00e5rd","year":"2018","unstructured":"Potteg\u00e5rd A, Friis S, Verdoodt F, et al. Use of prescription drugs among women diagnosed with epithelial ovarian cancer in Denmark. Acta Obstet Gynecol Scand. 2018;97:1332\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1062_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/ageing\/afaa029","volume":"49","author":"C Lundby","year":"2020","unstructured":"Lundby C, Jensen J, Larsen SP, et al. Use of medication among nursing home residents: a Danish drug utilisation study. Age Ageing. 2020;49:814\u201320.","journal-title":"Age Ageing"},{"key":"1062_CR10","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1016\/S2666-7568(21)00170-7","volume":"2","author":"V Kosjerina","year":"2021","unstructured":"Kosjerina V, Carstensen B, J\u00f8rgensen ME, et al. Discontinuation of diabetes medication in the 10 years before death in Denmark: a register-based study. Lancet Healthy Longev. 2021;2:e561\u201370.","journal-title":"Lancet Healthy Longev"},{"key":"1062_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577\u201389.","journal-title":"N Engl J Med"},{"key":"1062_CR12","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"1062_CR13","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383\u20139.","journal-title":"Lancet"},{"key":"1062_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","volume":"364","author":"HM Colhoun","year":"2004","unstructured":"Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685\u201396.","journal-title":"Lancet"},{"key":"1062_CR15","doi-asserted-by":"crossref","unstructured":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253\u20139.","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"1062_CR16","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2016","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, et al. Data resource profile: the Danish National Prescription Registry. Int J Epidemiol. 2016;46:798\u2013798f.","journal-title":"Int J Epidemiol"},{"key":"1062_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"key":"1062_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39:42\u20135.","journal-title":"Scand J Public Health"},{"key":"1062_CR19","unstructured":"R Core Team. R: a language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing; 2021. https:\/\/www.R-project.org\/."},{"key":"1062_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00228-014-1677-y","volume":"70","author":"A Potteg\u00e5rd","year":"2014","unstructured":"Potteg\u00e5rd A, dePont Christensen R, Houji A, et al. Primary non-adherence in general practice: a Danish register study. Eur J Clin Pharmacol. 2014;70:757\u201363.","journal-title":"Eur J Clin Pharmacol"},{"key":"1062_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pds.4145","volume":"26","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Hallas J. New use of prescription drugs prior to a cancer diagnosis. Pharmacoepidemiol Drug Saf. 2017;26:223.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01062-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01062-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:19:36Z","timestamp":1698229176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01062-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01062-0","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"7 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Royal Library, Copenhagen University Library. This research received no external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"K.S.J., T.S.P., M.B.C., and A.P. have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"K.S.J. and A.P. conceived the study. All authors contributed to the study design. K.S.J. coordinated the study and A.P., M.B.C., and T.S.P. supervised the study. K.S.J. performed the statistical analyses and all authors contributed to the interpretation of the data. K.S.J. wrote the first draft of the manuscript. All authors revised the manuscript and approved the final version of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The data supporting this study\u2019s findings are available from Statistics Denmark. Restrictions apply to the availability of these data and are therefore not publicly available.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Software code can be provided upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}